Preetha Pharmacy And Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-07-2024
- Paid Up Capital ₹ 5.00 M
as on 30-07-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.06 Cr
as on 30-07-2024
- Revenue -14.82%
(FY 2023)
- Profit -208.55%
(FY 2023)
- Ebitda -79.74%
(FY 2023)
- Net Worth -3.98%
(FY 2023)
- Total Assets 1.48%
(FY 2023)
About Preetha Pharmacy And Labs
The Corporate was formerly known as Indo Beverian Exports Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.06 Cr.
Subramaniam Muthiah and Salin Balaji serve as directors at the Company.
- CIN/LLPIN
U85100TN1995PTC030295
- Company No.
030295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai-600 018., Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Preetha Pharmacy And Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramaniam Muthiah  | Director | 23-Feb-1995 | Current |
| Salin Balaji | Director | 23-Feb-1995 | Current |
Financial Performance of Preetha Pharmacy And Labs.
Preetha Pharmacy And Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.82% decrease. The company also saw a substantial fall in profitability, with a 208.55% decrease in profit. The company's net worth dipped by a decrease of 3.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Preetha Pharmacy And Labs?
In 2023, Preetha Pharmacy And Labs had a promoter holding of 98.60% and a public holding of 1.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹20.62 M
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 1.16 Cr
- Reliance Commercial Finance Private Limited : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2011 | Reliance Commercial Finance Private Limited | ₹9.00 M | Open |
| 20 Oct 2010 | Corporation Bank | ₹4.10 M | Open |
| 22 Jun 2010 | Corporation Bank | ₹5.40 M | Open |
| 16 Nov 2009 | Corporation Bank | ₹2.12 M | Open |
How Many Employees Work at Preetha Pharmacy And Labs?
Unlock and access historical data on people associated with Preetha Pharmacy And Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Preetha Pharmacy And Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Preetha Pharmacy And Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.